DMTR.F Stock Overview
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
3-D Matrix, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1.11 |
| 52 Week High | JP¥1.17 |
| 52 Week Low | JP¥1.11 |
| Beta | 0.91 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -72.01% |
| 5 Year Change | -74.72% |
| Change since IPO | -97.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| DMTR.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -3.2% |
| 1Y | n/a | -3.7% | 19.3% |
Return vs Industry: Insufficient data to determine how DMTR.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how DMTR.F performed against the US Market.
Price Volatility
| DMTR.F volatility | |
|---|---|
| DMTR.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DMTR.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DMTR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 108 | Jun Okada | www.3d-matrix.co.jp |
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
3-D Matrix, Ltd. Fundamentals Summary
| DMTR.F fundamental statistics | |
|---|---|
| Market cap | US$77.50m |
| Earnings (TTM) | -US$12.89m |
| Revenue (TTM) | US$18.31m |
4.3x
P/S Ratio-6.2x
P/E RatioIs DMTR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMTR.F income statement (TTM) | |
|---|---|
| Revenue | JP¥2.72b |
| Cost of Revenue | JP¥1.11b |
| Gross Profit | JP¥1.61b |
| Other Expenses | JP¥3.53b |
| Earnings | -JP¥1.91b |
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -27.77 |
| Gross Margin | 59.35% |
| Net Profit Margin | -70.38% |
| Debt/Equity Ratio | 3,098.7% |
How did DMTR.F perform over the long term?
See historical performance and comparison